Clinical Trial: Deucravacitinib Adherence Study
Study Status: Completed
Recruit Status: RECRUITING
Condition: Psoriasis
Study Type: INTERVENTIONAL
Official Title: Deucravacitinib Adherence Study
Brief Summary:
Psoriasis patients are very poorly adherent to topical treatment.If adherence issues are ignored, poor adherence may limit the real-world efficacy of deucravacitinib, too.Forty psoriasis patients recruited from Wake Forest Baptist Health Dermatology Clinic will be enrolled.Twenty will be randomized to a reporting intervention designed to promote better adherence and the remaining 20 patients will serve as controls who will not receive a reporting intervention.Through qualitative interviews of the 40 patients…
Read more